Injectables Inventory: Track Units, Vials, Expiry
The short answer
Injectable inventory is a per-unit ledger problem: Botox tracked by units drawn against each reconstituted vial, fillers tracked by syringe with lot numbers tied to the client record, expiration dates monitored before they become write-offs, and reorder points set from real usage. The discipline is charting product at the moment of injection, not reconstructing it later.
Key takeaways
- Track units at the point of injection, tied to the client and provider; end-of-day recall is where product disappears.
- Lot numbers on the chart are a recall-readiness and safety requirement, not bureaucracy.
- Expiration management is a standing report, not a fridge archaeology session.
- Reorder points come from usage velocity per product, so cash isn't parked in slow stock while fast movers run out.
Why injectable inventory is different from other clinic supplies
Botox costs $400 to $600 per 100-unit vial. Juvederm costs $250 to $400 per syringe. Restylane, Sculptra, Radiesse, each syringe represents $200 to $500 in product cost. A clinic ordering $15,000 to $20,000 in injectables per month is handling products with the per-unit value of fine jewelry. Yet most clinics track injectable inventory the way they track paper towels: they order when they run low and have no idea how many units are wasted per month.
The additional complication is perishability. Botox has a shelf life of 36 months unopened but only 24 hours once reconstituted (some clinics extend to 2 weeks with refrigeration, but this is off-label). A vial reconstituted on Friday afternoon for a client who no-shows represents $400 to $600 in potential waste. Filler has a longer shelf life (12 to 24 months unopened) but must be tracked by lot number for manufacturer recall compliance.
Botox unit tracking
From vial to injection
Each Botox vial contains 100 or 200 units (100U is standard). When a provider reconstitutes a vial, your tracking should record: the vial lot number, the date and time of reconstitution, the provider who reconstituted it, and the saline volume used (which determines concentration). As the provider treats clients throughout the day, they log units injected per client per treatment area. At the end of the day, the remaining units are counted. The sum of units injected plus units remaining should equal the total reconstituted. If it does not, you have a waste or documentation problem.
The multi-provider challenge
In a clinic with 2 to 3 injectors, the most common inventory problem is shared vials. Provider A reconstitutes a 100U vial, uses 60 units, and leaves 40 units in the fridge. Provider B uses 30 of those units. 10 units remain at end of day and are discarded. Neither provider's records show the 10-unit waste because neither tracked the handoff. Solution: assign each reconstituted vial to a single provider. If Provider A's schedule does not require all 100 units, reconstitute a half-vial (50U with proportional saline). The waste from smaller reconstitution is less than the waste from untracked shared vials.
Filler syringe management
Per-client allocation
Each filler syringe is single-use and should be assigned to a single client. Never transfer product between syringes or between clients. Track: the product name and lot number, the client it was allocated to, the treatment area and volume injected, and whether any product remained ("partial syringe" tracking). Some clinics offer to store partially used syringes for the client's next visit (labeled, refrigerated, used within 30 days). This reduces waste but requires careful documentation and a storage protocol.
Lot number tracking
Every filler syringe has a lot number printed on the packaging. Record this in the client's treatment record. In the event of a manufacturer recall (rare but it happens, Allergan recalled specific Juvederm lots in 2023), you need to identify every client who received product from the affected lot and notify them. This is not optional. If you cannot identify affected clients because you did not track lot numbers, you face both legal liability and the operational nightmare of contacting every filler client from the relevant time period.
Expiration management
First-in-first-out (FIFO) is the rule. New product goes to the back of the shelf. The closest expiration date is always used first. Your inventory system should flag products approaching expiration 90 days out (alert to increase usage), 30 days out (alert to prioritize before waste), and at expiration (quarantine and dispose). A single expired vial of Botox is $500. Ten expired syringes of filler across a year is $3,000 to $5,000. These are preventable losses.
Reorder point strategy
Calculate your weekly consumption rate for each product: if you use 8 vials of Botox per week and your supplier delivers in 3 business days, your reorder point is 4 vials (approximately 3 days of supply plus a 1-day buffer). Order too late and you run out mid-week, cancelling or rescheduling clients. Order too early and you stockpile product, tying up cash and increasing expiration risk. Most suppliers offer weekly standing orders, set the quantity to your average weekly consumption and adjust monthly based on seasonal demand (Botox demand peaks before holidays and wedding season).
Waste reduction strategies
Schedule Botox clients in clusters. Instead of spreading Botox appointments across the day (requiring multiple vial reconstitutions), cluster 4 to 6 Botox clients in a morning block. One or two reconstituted vials serve the entire block with minimal waste. An afternoon Botox client whose appointment is the only one that day will waste 40 to 60 unused units from a freshly reconstituted vial.
Track waste by provider. Some providers consistently waste more product than others, they reconstitute more than needed, they inject slightly more per area, or they discard partially used vials at end of day instead of refrigerating. Monthly waste reports by provider identify training opportunities. The goal is under 5% waste rate (units wasted versus units purchased). Above 10% requires immediate process review.
Track units, not dollars
Dollar-based inventory tracking ("we spent $18,000 on Botox this month") tells you nothing about waste, utilization, or profitability per treatment. Unit-based tracking ("we purchased 3,600 units, injected 3,280, wasted 320-8.9% waste rate") tells you exactly where money is lost and how to fix it. Every injectable clinic should know their waste rate to the tenth of a percent. The clinics that do not are leaving $15,000 to $30,000 per year on the shelf.
Charting-driven inventory is part of Gracero's charting & consent with checkout on payments & POS; the treatment-record side is covered in the laser series-tracking guide's sibling workflows.
Frequently asked questions
How should Botox units be tracked across multiple providers?
Each reconstituted vial becomes a small ledger: units drawn per treatment, by whom, for which client, with the running balance visible. Multi-provider clinics lose product when two injectors draw from shared vials with nobody reconciling; per-treatment charting against the specific vial closes that gap and makes the waste line (expired remainder, spillage) an honest number instead of a mystery.
Why do lot numbers matter on the client chart?
Because recalls and adverse-event questions arrive by lot: when a manufacturer flags a batch, you need every client who received it in one query, not a week of paper hunting. Lot capture at injection also completes the clinical record for board or insurer questions. It's a two-second scan or tap at charting time that buys recall-readiness permanently.
How do you set reorder points for injectables?
From usage velocity per product: average weekly consumption times lead time, plus a safety margin sized to how painful a stockout is for that product. Fast movers like neurotoxin deserve tighter monitoring and standing orders; episodic products (specialty fillers, biostimulators) should be ordered against booked treatment plans rather than kept deep on the shelf tying up cash.
Can inventory tracking be part of the charting workflow?
It should be: when the provider charts the treatment (units, syringe, lot), the inventory ledger decrements automatically, so the count is a by-product of good clinical documentation rather than a separate chore. That's how Gracero wires it: product usage recorded at charting flows straight into inventory levels, expiry visibility, and per-provider usage reporting.
Content writer and social media specialist. Covers clinic branding, content marketing, and client engagement strategies for aesthetic and wellness businesses.